FIGS heads into its third-quarter report carrying the kind of momentum that makes a stock both exciting and dangerous to own. Management has raised its full-year outlook three quarters in a row, nearly doubling its original growth forecast, and the shares have climbed about 35% since the last report while the S&P 500 went nowhere. The question now is whether the company can keep feeding that story at the same moment it is rerouting roughly a third of its production away from a blocked Jordanian supplier.

The Street expects earnings of $0.07 a share on revenue of about $181.2 million, which would mark roughly 19.5% top-line growth and a 40% jump in profit from the year-ago $0.05. That is healthy growth, but it is a visible step down from the 29% pace of the second quarter and the string of 25%-plus quarters before it. The whisper number sits at $0.09, two cents above consensus. On a profit base this small, that gap is meaningful, and it signals that the real bar is closer to a clear beat than a simple match. The bigger tell is the full-year math. Management now guides to roughly $757.3 million in 2026 revenue, while consensus sits near $728.7 million, below even the company's previous range. Analysts are effectively not believing the latest raise, which leaves room for upside if the quarter lands near guidance, and a credibility problem for the company if it does not.

The operating drivers that powered last quarter's beat deserve the closest attention. Active customers grew 13% to 3.1 million, an acceleration for the third straight period, and net revenue per active customer hit a record $229, topping its pandemic peak. Continued gains in both would confirm that growth is coming from deeper engagement rather than discounting. Non-scrubware, up 40% last quarter, and international, up 67% across 85 markets, are the newer engines; sustained strength there would support the idea that FIGS is becoming a broader healthcare lifestyle brand. Early contributions from the Bupa Dental Care rollout across some 400 UK centers and the Fibrex fabric expansion would add texture to that thesis.

The Jordan disruption is the chief swing factor. Management warned that third-quarter inventory would fall by double digits year over year as it shifts to other suppliers and leans on air freight. Thin inventory can cap sales if popular sizes and colors go out of stock, and expedited shipping eats into margins. Gross margin will also be noisy, since part of the $20.5 million tariff refund remains in inventory and will flow through cost of goods. Investors should look past the headline figure to whether underlying gross margin is still tracking toward modest improvement from last year's 66.5%, and whether SG&A leverage is offsetting the drag from a richer non-scrubware mix.

Sentiment has swung from slightly bearish before the last report to modestly bullish now, and the stock sits at $20.48, well above its 200-day average of $13.30 and within about 2% of its post-earnings high of $20.88. A stock testing a breakout after a run this sharp tends to need confirmation rather than mere reassurance.

Ultimately, this report hinges on whether FIGS can hold growth near its 20% annual target and reaffirm or lift its outlook while absorbing supply-chain costs. If customer metrics keep climbing and margins hold up despite air freight, the gap between guidance and consensus becomes a tailwind. If the Jordan transition shows up as lost sales or a guidance trim, the recent rally leaves little cushion.